proton pump inhibitors

You have access
Proton Pump Inhibitors Ameliorate Capecitabine-induced Hand-Foot Syndrome in Patients With Breast Cancer: A Retrospective Study
MIHO TAKEMURA, KENJI IKEMURA, TETSUHIRO YOSHINAMI, YUJI TOYOZUMI, TAKUYA SHINTANI, MIKIKO UEDA, KENZO SHIMAZU and MASAHIRO OKUDA

Anticancer Research May 2022, 42 (5) 2591-2598; DOI: https://doi.org/10.21873/anticanres.15737
You have access
Impact of the Use of Proton Pump Inhibitors on Pembrolizumab Effectiveness for Advanced Urothelial Carcinoma
IKKO TOMISAKI, MIRII HARADA, AKINORI MINATO, YUJIRO NAGATA, RIEKO KIMURO, KATSUYOSHI HIGASHIJIMA, KENICHI HARADA and NAOHIRO FUJIMOTO

Anticancer Research March 2022, 42 (3) 1629-1634; DOI: https://doi.org/10.21873/anticanres.15638
You have access
Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer
MARTIN SVATON, MILADA ZEMANOVA, PETRA ZEMANOVA, JURAJ KULTAN, ONDREJ FISCHER, JANA SKRICKOVA, LENKA JAKUBIKOVA, MARKETA CERNOVSKA, MICHAL HRNCIARIK, MICHAL JIROUSEK, JANA KREJCI, DANIEL KREJCI, ONDREJ BILEK, JIRI BLAZEK, KAROLINA HURDALKOVA, MAGDA BARINOVA and BOHUSLAV MELICHAR

Anticancer Research April 2020, 40 (4) 2209-2217; DOI: https://doi.org/10.21873/anticanres.14182

Main menu